Issuance of Stock Acquisition Rights for Directors and Employees
First written in FY2018-Q2. 11 of 13 entries say "Advanced", first in FY2019-Q3. Latest entry: FY2026-H1.
- FY2026-H1AdvancedAnnual report
「Series 8 stock acquisition rights Resolution date 17 June 2026 Classes and number of eligible recipients (people) Company directors 3 Number of stock acquisition rights (units) (Note 1) 400 Class, description and number of shares underlying the stock acquisition rights (shares) (Note 1) Common shares 40,000」
Pursuant to the resolution of 17 June 2026, the company granted Series 8 stock acquisition rights representing 40,000 common shares to 3 directors. - FY2025Increase in forfeitures of stock acquisition rightsAnnual report
「Exercised — — — — Forfeited 20,000 — 1,000 3,000 Unexercised balance — 10,000 17,500 23,500」
Of the stock options, 20,000 shares granted in 2015, 1,000 granted in 2021 and 3,000 granted in 2022 were forfeited because the rights were not exercised. The unexercised balances were 10,000 shares granted in 2018, 17,500 granted in 2021 and 23,500 granted in 2022. - FY2023AdvancedAnnual report
「Before vesting (Shares) End of previous consolidated fiscal year 28,500 Forfeited 8,000 Vested 20,500 Unvested balance —」
For the 2021 stock options, 20,500 shares vested and 8,000 shares were forfeited. - FY2022AdvancedAnnual report
「Series 7 stock acquisition rights (approved by resolutions of the annual general meeting of shareholders held on 25 March 2022 and the Board of Directors meeting held on 15 December 2022)" Classes and number of eligible recipients (people): company directors 2; company employees 26" Number of shares underlying the stock acquisition rights (shares): 30,000」
As 2022 stock options, the company granted options representing 30,000 common shares to 2 directors and 26 employees. - FY2021AdvancedAnnual report
「2021 stock options Classes and number of eligible recipients Company directors 2 Company employees 16 Number of stock options by class of shares Common shares 30,000 shares Grant date 17 December 2021」
On 17 December 2021, the company granted stock options representing 30,000 common shares to 2 directors and 16 employees. - FY2020AdvancedAnnual report
「1 January 2020–31 December 2020 32,000 2,519,600」
The company issued 32,000 shares through the exercise of stock acquisition rights during 2020, bringing the total number of issued shares to 2,519,600. - FY2020-Q3AdvancedAnnual report
「1 July 2020–30 September 2020 2,400 2,493,200」
The exercise of stock acquisition rights resulted in the issuance of 2,400 shares during the third quarter, bringing the total number of issued shares to 2,493,200. - FY2020-Q2AdvancedAnnual report
「1 April 2020–30 June 2020 3,200 2,490,800」
The exercise of stock acquisition rights increased the total number of issued shares by 3,200 between April and June 2020, bringing the total to 2,490,800. - FY2019AdvancedAnnual report
「1 January 2019–31 December 2019 14,400 2,487,600」
During 2019, 14,400 shares were issued through the exercise of stock acquisition rights, bringing the total number of issued shares to 2,487,600. - FY2019-Q3AdvancedAnnual report
「Between 1 October 2019 and 31 October 2019, the exercise of stock acquisition rights increased the total number of issued shares by 5,600 shares and increased capital and capital surplus by ¥876 thousand each.」
During October 2019, exercises of the previously disclosed stock acquisition rights progressed, increasing the number of issued shares by 5,600. - FY2018-Q2First statedAnnual report
「Number of stock acquisition rights (units) 100 Number of shares underlying the stock acquisition rights (shares) 10,000 Amount to be paid in upon exercise of the stock acquisition rights (yen) 1,043 Exercise period From 22 May 2020 To 29 February 2028」
During the second quarter, the company issued 100 stock acquisition rights, representing 10,000 underlying shares, to directors, employees and others. The exercise price was ¥1,043 per share, and the exercise period runs from 22 May 2020 to 29 February 2028.